Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Biofrontera Reports Third Quarter 2019 Financial Results and Revises Guidance

Biofrontera AG - American Depositary Shares (BFRA) 
Company Research Source: GlobeNewswire
Leverkusen, Germany, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced its results for the first nine months ended September 30, 2019. At the same time, the guidance for fiscal 2019 has been adjusted. Key financial figures for the first nine months of 2019 In EUR thousands  9M 2019 9M 2018 Change Revenue 19,059 14,552 +31% Research and development costs (3,215) (3,219) 0% General administrative costs (12,108) (7,283) -66% Sales and marketing costs (20,635) Show less Read more
Impact Snapshot
Event Time:
BFRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BFRA alerts
Opt-in for
BFRA alerts

from News Quantified
Opt-in for
BFRA alerts

from News Quantified